Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I spoke with two of the principals of the 13D grou

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155139
(Total Views: 713)
Posted On: 08/06/2021 4:23:21 PM
Posted By: CTMedic
Re: Evil Rabbit #98926
I spoke with two of the principals of the 13D group late this spring (prior to the FDA letter) as it became clear to me that CD12 had failed and that Cytodyn/Amarex had failed to marshal the trial appropriately and then compounded that by the uneven rollout of the data. IMO this poor/rushed reporting of the data doomed the chances of EUA (last data released was the most impactful, 82% mortality reduction at 14 days in critical intubated or ECMO patients).

I am frustrated with Cyotdoyn’s leadership, but many obstacles appear to have been but placed before them whereas others have been presented a smooth and gilded path.

Like the serpent’s whisper, the 13D organizers promised that they would easily prevail and quickly
realize that potential of Leronlimab, where the current board has not. After much listening, I came to appreciate that I was being told more what I wanted to hear than what was likely to be true.

Lots of firepower on many levels in the 13D group, but it seems that they have over-estimated themselves while simultaneously underestimating the difficulty of the process they have undertaken.

I believe they will now pay a hefty price for these miscalculations.

I’ll stick with the science, as that is the only part of this process which is not opaque to me.

Success for Leronlimab and Cytodyn investors remains delayed not denied.


(22)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us